跳至主要内容
临床试验/ITMCTR2000003019
ITMCTR2000003019尚未招募4 期

A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy

Huangshi Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1. patients with novel coronavirus pneumonia confirmed by pathogenic detection;
  • 2. Fever, respiratory tract and other symptoms, the change of pneumonia can be seen in imaging;
  • 3. Aged 18 to 80 years;
  • 4. Signed informed consent.

排除标准

  • 1. Pregancy or lactating women;
  • 2. People with allergies or allergies to traditional Chinese medicine
  • 3. Severe Primary disease such as uncontrolled and metastasis malignancy, hematopathy, HIV;
  • 4. Obstructive pneumonia caused by lung tumors, severe pulmonary interstitial fibrosis, alveolar proteinosis, allergic reaction alveolitis;
  • 5. Previous immunodepressant within 6 months before study entry or Receipt of a solid-organ or bone marrow transplant;
  • 6. Severe mental illness or inability to cooperate with investigators.

研究者

发起方
Huangshi Hospital of Traditional Chinese Medicine

相似试验

A multicenter, randomized, controlled trial for... | 临床试验